Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Boundless Bio
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
May 13, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
May 06, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
April 11, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
April 08, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Announces Pricing of Initial Public Offering
March 27, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Multiple Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2024
March 05, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Preclinical Data on the Discovery of its Second ecDNA-Directed Therapeutic Candidate, BBI-825, at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Upcoming Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints New Board Members and Establishes Clinical Advisory Board
October 02, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate VERZENIO® (abemaciclib) in Combination with BBI-355 in Patients with CDK4 or CDK6 Amplified Solid Tumors
September 19, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate LYTGOBI® (futibatinib) in Combination with BBI-355 in Patients with FGFR Amplified Solid Tumors
September 18, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Jami Rubin as Chief Financial Officer
July 31, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 2023 Jefferies Healthcare Conference
June 01, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-355 in Patients with Solid Tumors Harboring Oncogene Amplification
May 09, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Data on the Novel Discovery of CHK1 as an Extrachromosomal DNA (ecDNA) Essential Target in Oncogene Amplified Cancers at the American Association for Cancer Research Annual Meeting 2023
April 17, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days
April 11, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 04, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Upcoming Presentation at the American Association for Cancer Research Annual Meeting 2023
March 15, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Participate at Two Upcoming Investor Conferences
November 15, 2022
From
Boundless Bio
Via
Business Wire
Team Led by Boundless Bio Scientific Founders Receives $25M Award to Better Understand Extrachromosomal DNA (ecDNA) Through Cancer Grand Challenges
June 16, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 2022 Jefferies Healthcare Conference
June 06, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Sara Weymer as Vice President, Clinical Operations
June 03, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Data on the Novel Discovery of the Association Between Extrachromosomal DNA (ecDNA) and Replication Stress at the American Association for Cancer Research Annual Meeting 2022
April 08, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Klaus Wagner, M.D., Ph.D., as Chief Medical Officer
February 22, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Amy Berkley, Ph.D., as Vice President, Program Team Leadership and Strategic Alliances
February 07, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the Guggenheim Oncology Conference
February 02, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine
January 17, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Jennifer Lew to its Board of Directors
January 05, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Boundless Bio
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
